Recursion outlines runway into early 2028 while maintaining 2026 cash operating expenses under $390M
Financial framing remained anchored on the same runway and 2026 cash operating expense guidance, while Q1 2026 highlighted a "30% year-over-year reduction" in cash operating expenses and quarter-end ...
Recursion Pharmaceuticals’ latest earnings call struck a cautiously optimistic tone as management highlighted its first AI-enabled clinical proof-of-concept, major cost cuts, and an extended cash ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated ...
This Route 22 exit in Lehigh Valley is one of most stressful for motorists in Pa. The Airport Road exit of Route 22 is the second most stressful in Pennsylvania for motorists, according to a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results